packageVorapaxar

vorapaxar

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vorapaxar is a platelet aggregation inhibitor used to reduce the risk of cardiovascular events in patients who have had a myocardial infarction. It is an approved medicine, though its marketing authorisation in the European Union has been withdrawn, so its use is now limited to other regions.

Summary written by glm-5.3-flash from Wikidata Q7941753 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vorapaxar
ATC codes:B01AC26
DrugBank:DB09030
PubChem CID:10077130
ChEBI:82702
Wikidata:Q7941753
formula:C29H33FN2O4
molar mass:492.591 g/mol (PubChem CID 10077130)
logP:5.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown